Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Oligo Chemistry

Characterisation of Therapeutic Oligonucleotides in Early Drug Discovery

Oligonucleotides are fast becoming a globally recognised form of therapeutic treatment. But how easy is it to analyse them? Director of AstraZeneca, Tomas Leek takes us through the analytic challenges of the early-stage oligonucleotide characterisation.
Immuno-Oncology

Multi-Specific Protein Modalities For Solid Tumours

An interview with Rajika Perera, Chief Executive Officer, Poseidon Laboratory
Cell Line Development

Cell Line Development with Advanced Cell Line Engineering

The need to demonstrate clonality for regulatory approval means that now more than ever, the industry must look towards streamlining and optimising clone selection efficacy. We sat down with senior representatives from Ichnos Sciences and Sanofi to learn how.
NextGen Therapeutics

Harnessing Bispecific T Cell Engagers and T Cell Primers in Cancer Treatment

Stimulating T cells using bispecific antibody immunotherapies can lead to transformational clinical benefits for cancer patients. So how exactly is the industry addressing the need for targeted T cell-based immunotherapies?
Peptide Chemistry

Peptides Green Chemistry Strategies and Methods

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Peptides Green Chemistry Strategies and Methods’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Drug Discovery & Development

Are Genomic Technologies the Key to Unlock Precision Immunotherapies?

The power of the genome has enormous implications for immunotherapy
NextGen Therapeutics

Bispecific and Multi-Specific Antibodies - Formats, Applications, and Paths to the Clinic

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our November Discussion Group addressing ‘Bi-and Multi-Specific Antibodies - Formats, Applications, and Paths to the Clinic’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Manufacturing & Bioprocessing

Streamlining Stem Cell Manufacturing

Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Streamlining Stem Cell Manufacturing' was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market's growth, its priorities, future outlook, and challenges.

Advancing The Implementation Of Automation Technologies For Cell Therapy Development

Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our November Discussion Group addressing ‘Advancing The Implementation Of Automation Technologies For Cell Therapy Development' was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market's growth, its priorities, future outlook, and challenges.
Stem Cell Therapy

Advancing Stem Cell Manufacturing

Regenerative medicine is a highly promising branch of pharmacology. With the growing demand for stem cell therapies, the need for streamlined manufacturing is more critical than ever. We sat down with senior representatives from Procella Therapeutics, the University of Reading, and Newcastle University to learn more about the future of stem cell production.
Stem Cell Therapy

Three Studies in 3D Stem Cell Culture

Dr Darius Widera shows us three case studies on 3D stem cell cultivation using fibrin, nanofibrillar cellulose, and hybrid scaffolds
NextGen Therapeutics

A New Cancer-Killing Bispecific Antibody Working Toward the Clinic in 2022

The joint development project by Alligator Bioscience and Aptevo Therapeutics, ALG.APV-527, shows potential in targeting solid tumours

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery